Cargando…
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
INTRODUCTION: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083310/ https://www.ncbi.nlm.nih.gov/pubmed/37051428 http://dx.doi.org/10.3389/fped.2023.1020865 |
_version_ | 1785021480910716928 |
---|---|
author | Seidel, Alina Jacobsen, Eva-Maria Fabricius, Dorit Class, Magdalena Zernickel, Maria Blum, Carmen Conzelmann, Carina Weil, Tatjana Groß, Rüdiger Bode, Sebastian F. N. Renk, Hanna Elling, Roland Stich, Maximillian Kirchhoff, Frank Debatin, Klaus-Michael Münch, Jan Janda, Aleš |
author_facet | Seidel, Alina Jacobsen, Eva-Maria Fabricius, Dorit Class, Magdalena Zernickel, Maria Blum, Carmen Conzelmann, Carina Weil, Tatjana Groß, Rüdiger Bode, Sebastian F. N. Renk, Hanna Elling, Roland Stich, Maximillian Kirchhoff, Frank Debatin, Klaus-Michael Münch, Jan Janda, Aleš |
author_sort | Seidel, Alina |
collection | PubMed |
description | INTRODUCTION: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures. METHODS: Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay. RESULTS: We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children. DISCUSSION: Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1. |
format | Online Article Text |
id | pubmed-10083310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100833102023-04-11 Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection Seidel, Alina Jacobsen, Eva-Maria Fabricius, Dorit Class, Magdalena Zernickel, Maria Blum, Carmen Conzelmann, Carina Weil, Tatjana Groß, Rüdiger Bode, Sebastian F. N. Renk, Hanna Elling, Roland Stich, Maximillian Kirchhoff, Frank Debatin, Klaus-Michael Münch, Jan Janda, Aleš Front Pediatr Pediatrics INTRODUCTION: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures. METHODS: Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay. RESULTS: We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children. DISCUSSION: Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083310/ /pubmed/37051428 http://dx.doi.org/10.3389/fped.2023.1020865 Text en © 2023 Seidel, Jacobsen, Fabricius, Class, Zernickel, Blum, Conzelmann, Weil, Groß, Bode, Renk, Elling, Stich, Kirchhoff, Debatin, Müench and Janda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Seidel, Alina Jacobsen, Eva-Maria Fabricius, Dorit Class, Magdalena Zernickel, Maria Blum, Carmen Conzelmann, Carina Weil, Tatjana Groß, Rüdiger Bode, Sebastian F. N. Renk, Hanna Elling, Roland Stich, Maximillian Kirchhoff, Frank Debatin, Klaus-Michael Münch, Jan Janda, Aleš Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection |
title | Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection |
title_full | Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection |
title_fullStr | Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection |
title_full_unstemmed | Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection |
title_short | Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection |
title_sort | serum neutralizing capacity and t-cell response against the omicron ba.1 variant in seropositive children and their parents one year after sars-cov-2 infection |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083310/ https://www.ncbi.nlm.nih.gov/pubmed/37051428 http://dx.doi.org/10.3389/fped.2023.1020865 |
work_keys_str_mv | AT seidelalina serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT jacobsenevamaria serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT fabriciusdorit serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT classmagdalena serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT zernickelmaria serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT blumcarmen serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT conzelmanncarina serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT weiltatjana serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT großrudiger serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT bodesebastianfn serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT renkhanna serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT ellingroland serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT stichmaximillian serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT kirchhofffrank serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT debatinklausmichael serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT munchjan serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection AT jandaales serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection |